Standout Papers
Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
2015
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
2020 Standout
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Laser in situ keratomileusis to correct high myopia
1997
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Cardiotoxic effects of anthracycline–taxane combinations
2003
Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review
2021
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Presurgical Serum Albumin Levels Predict Survival Time from Glioblastoma Multiforme
1999
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
2020
Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis
2021
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
2012
Platelet Count and Preoperative Haemoglobin Do Not Significantly Increase the Performance of Established Predictors of Renal Cell Carcinoma-Specific Mortality
2007
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin
2002
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
2020 Standout
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials
2005
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Human Corneal Thickness and Its Impact on Intraocular Pressure Measures
2000 Standout
Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
2020
Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?
2005
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects
2015
2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
2018
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Iron oxide MR contrast agents for molecular and cellular imaging
2004 Standout
Hormone receptors in malignancy
1992
Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis
2020
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2020 Standout
Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer
2001
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age‐Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults
2016 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Incidence of venous thromboembolism in hospitalized patients with COVID‐19
2020
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
2014
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies
2006
Concomitant Effect of Topical Ubiquinone Q10 and Vitamin E to Prevent Keratocyte Apoptosis After Excimer Laser Photoablation in Rabbits
2002
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
2015
Hematologic Consequences of the Coronavirus Crisis—Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community
2020
Excimer laser photorefractive keratectomy
1995
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease
2004
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness
2021
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Prognostic Factors in Patients with Advanced Renal Cell Carcinoma
2004
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Maximized Reduction of Primary Breast Tumor Size Using Preoperative Chemotherapy With Doxorubicin and Docetaxel
1999
Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
2008
Cytokine Storm
2020 Standout
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
2020 Standout
Conversion of Alloantigen-Specific CD8+ T Cell Anergy to CD8+ T Cell Priming through In Vivo Ligation of Glucocorticoid-Induced TNF Receptor
2006 StandoutNobel
Mechanisms of Pulsed Laser Ablation of Biological Tissues
2003 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Works of Alexia Bertuzzi being referenced
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas
2002
Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide
2002
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy
2012
Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas
2009
The “old drug” dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas
2007
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303
2017
Prognostic Factors for Survival inMetastatic Renal Cell Carcinoma:Retrospective Analysis from109 Consecutive Patients
1997
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
2020 Standout
Phase II Study of Imatinib in Advanced Chordoma
2012
Estrogen Receptors in Renal Carcinoma1
1980
Efficacy of Corticosteroids in Reversing Regression After Myopic Photorefractive Keratectomy
1993
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
1997
Corticosteroids vs Diclofenac in the Treatment of Delayed Regression After Myopic Photorefractive Keratectomy
1993
Randomized study of single vs double exposure in myopic PRK.
1993
Treatment of Primary or Metastatic Pleural Effusion with Intracavitary Cytosine Arabinoside and Cisplatin: A phase II study
1994
Randomized Study of Single vs Double Exposure in Myopic PRK
1993
Clinical and Pharmacologic Study of the Epirubicin and Paclitaxel Combination in Women With Metastatic Breast Cancer
2001